COVID-19(11) Result(9) significantly higher(9) Patient(9) SARS-CoV-2(7) interval(6) RT-PCR(6) treatment for COVID-19(6) Mild(6) group(6) Safe(6) viral clearance rate(6) approved(6) Infection(6) patients with COVID-19(6) COVID-19 infection(6) Follow-up(6) primary endpoint(6) Sofosbuvir/ledipasvir(6) negative RT-PCR(6) Randomized controlled trial(6) addition(6) Open-label(6) was done(6) viral clearance(6) treatments for COVID-19(6) Efficacy and safety(6) moderate(6) Serious Adverse Event(6) three groups(6)